RevMab

anti-MUC-17 (Mucin-17) (human), Rabbit Monoclonal (RM517)

CHF 468.00
In stock
REV-31-1409-00-R100100 µlCHF 468.00
More Information
Product Details
Synonyms Mucin-17; Small Intestinal Mucin-3 (MUC-3)
Product Type Recombinant Antibody
Properties
Clone RM517
Isotype Rabbit IgG
Source/Host Rabbit
Immunogen/Antigen A peptide corresponding to residues near the C-terminus of human Muc17.
Application

Immunohistochemistry (IHC): 1:100-1:200

Crossreactivity Human
Specificity

This antibody reacts to human Muc-17 (Mucin-17).

Purity Protein A purified.
Purity Detail Protein A affinity purified from an animal origin-free culture supernatant.
Concentration N/A
Formulation Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide.
Isotype Negative Control

Rabbit IgG

Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Accession Number Q685J3
Declaration Manufactured by RevMab Biosciences.
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Membrane mucins have several functions in epithelial cells including cytoprotection, extravasation during metastases, maintenance of luminal structure, and signal transduction. MUC-17, contains an extended, repetitive extracellular glycosylation domain and a carboxyl terminus with two EGF-like domains, a SEA module domain, a transmembrane domain, and a cytoplasmic domain with potential serine and tyrosine phosphorylation sites. MUC-17 interacts via its C-terminus with PDZK1 and this interaction appears important for proper localization. MUC-17 probably plays a role in maintaining homeostasis on mucosal surfaces. Increased expression of this molecule has been reported in colon cancer.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.